Related Experiment Videos
Cholestasis as a presenting feature of acute Epstein-Barr virus infection
1Department of Procreation and Developmental Medicine, University of Pisa, Italy.
The Pediatric Infectious Disease Journal
|July 24, 2001
Insights
Epstein-Barr virus (EBV) disease can affect the liver, but cholestasis is a rare clinical sign in children. This study highlights three pediatric cases where cholestasis was the initial symptom of EBV infection.
Area of Science:
- Pediatric Hepatology
- Infectious Diseases
- Virology
Background:
- Epstein-Barr virus (EBV) infection is widespread, often causing infectious mononucleosis.
- Hepatic involvement, indicated by biochemical abnormalities, is frequently observed in EBV disease.
- Clinical manifestations of cholestasis (impaired bile flow) are uncommon in pediatric EBV cases.
Observation:
- The study focuses on three pediatric patients presenting with cholestasis.
- Cholestasis was the primary clinical feature leading to the diagnosis of EBV disease in these children.
- This presentation contrasts with the typical, less severe hepatic involvement seen in childhood EBV infections.
Findings:
- The findings indicate that cholestasis can be a presenting manifestation of Epstein-Barr virus disease in children.
- This challenges the notion that cholestasis is a rare clinical outcome of EBV in pediatric populations.
- The cases underscore the diverse clinical spectrum of EBV infection.
Implications:
- Pediatricians and infectious disease specialists should consider EBV as a potential cause of cholestasis in children.
- Early recognition of EBV-associated cholestasis may lead to timely diagnosis and management.
- Further research is warranted to understand the mechanisms behind EBV-induced cholestasis in pediatric patients.
Abstract:
Biochemical evidence of hepatic involvement in Epstein-Barr virus disease is common but clinical features of cholestasis are rare in children. We present three children with cholestasis as a presenting feature of Epstein-Barr virus disease.